Gut microbiota and metabolomic profile changes play critical roles in tacrolimus-induced diabetes in rats
Hyperglycemia is one of the adverse effects of tacrolimus (TAC), but the underlying mechanism is not fully identified. We used multi-omics analysis to evaluate the changes in the gut microbiota and metabolic profile of rats with TAC-induced diabetes.